Europe's drug regulator, namely the European Medicines Agency (EMA) has defended the use of the Coronavirus vaccine developed by AstraZeneca/Oxford University, despite growing fears over blood clots in some people inoculated with the jab.
U.K. Health Secretary Matt Hancock on Wednesday said there was "no evidence that vaccines" cause blood clots. The review is being carried out by EMA's Pharmacovigilance Risk Assessment Committee (PRAC), the Committee responsible for the evaluation of safety issues for human medicines.
"While all available vaccines in Canada are safe and effective, NACI still recommends that in the context of limited vaccine supply, initial doses of mRNA vaccines should be prioritized for those at highest risk of severe illness and death and highest risk of exposure to COVID-19", said a statement from the committee.
"The AstraZeneca vaccine was seen to be safe and efficacious and we would need to review the data".
"As a precautionary measure, we chose to postpone the date for the launch of vaccination in the DRC", said Health Minister Eteni Longondo.
Prof Jonathan Van-Tam, England's deputy chief medical officer, also pointed out the potential side effects of paracetamol to demonstrate why people shouldn't worry about the jab.
Pfizer/BioNTech vaccine doses for Europe, including the United Kingdom, are being produced in BioNTech's German manufacturing sites, as well as in Pfizer's manufacturing site in Belgium.
"There were a few very unusual and troubling cases which justify this pause and the analysis", Fischer told France Inter radio. Ford said the province would honour its commitment to people between those ages who have appointments, but it is unclear what will happen after that.
The updated advice comes a week after NACI revised its recommendations about dosage intervals for COVID-19 vaccines, saying the second dose could be stretched up to four months in order to increase the number of Canadians being vaccinated.
But a new agreement for Germany's IDT Biologika to help produce the single-shot Johnson & Johnson vaccine would offer Europe greater certainty, Germany's economy minister said Monday.
When the AstraZeneca vaccine was approved for emergency use in Britain last December, the shot was described as the "vaccine for the world".
One case of a thromboembolic event is under investigation, the ministry explained. And COVID-19 also causes blood clots. Vera Etches said the city would welcome AstraZeneca vaccines to speed up mass vaccination here.
The developers of Russia's successful Sputnik V vaccine also said they had reached production agreements in key European countries.
"You have the goal, it is about getting society back to normal and weathering the storm in the third wave".